4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-010608
President and CEO sold 14,343 shares at $15.00 ($215,145)
- President and CEO acquired 14,343 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McCarthy Sean A. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-03-03 | Exercise or conversion : show line 1 in the form | +14,343 | $1.13 | $16,264 | 16,322 | D |
| 2017-03-03 | Sale : show line 2 in the form | −14,343 | $15.00 | $215,145 | 1,979 | D |
| Open-market sales · 14,343 sh · avg $15.00 · $215,145 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-03-03 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −14,343 | 366,961 | D |
Loading xslF345X03/doc1.xml…